Value through InnovationJune 18 2013

Research & Innovation

For 125 years, research and development (R&D) has been the foundation of Boehringer Ingelheim's success and continues to be the major driver of innovative new medicines that help improve patient’s lives and address unmet therapeutic needs. Our privately held status affords us the opportunity to think long term about our R&D commitments in a way that is best suited to meet the unique challenges and long cycles of drug discovery and development.

Our constant quest for innovation is not limited to our own discoveries but includes successful ongoing collaborations. We actively pursue new collaborations with external partners, ranging from academic institutions to biopharmaceutical enterprises and start-up companies.

Research & Innovation Areas

The Drug Discovery Process

From discovery to a marketable drug is a long road, always led by curiosity. Find out more about what it takes to bring innovative medicines to patients.

read more
Our Research Centers

At Boehringer Ingelheim, research and development is conducted at four major research and development sites and three support centers in Europe, the Americas and Asia.

read more
Pipeline

Boehringer Ingelheim boasts one of the strongest late stage pipelines in the industry. We are making significant advances in areas of diabetes, oncology and others.

read more
Clinical Trials

Boehringer Ingelheim has a large and experienced global team managing and conducting clinical trials in many indications. Over the past decade we have conducted or sponsored 1,296 studies with 112 substances in 84 countries.

read more
Scientific Awards

Boehringer Ingelheim sponsors several awards to recognize individuals for a commitment to their work within the scientific arena.

read more
Partnerships

Boerhinger Ingelheim supports several academic and fellowship programs that share the goal of discovering, profiling and developing products of high therapeutic value.

read more